- Home
- SFBC vs PLX Comparison
SFBC vs PLX Comparison
Compare SFBC & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFBC
- PLX
- Stock Information
- Founded
- SFBC 1953
- PLX 1993
- Country
- SFBC United States
- PLX United States
- Employees
- SFBC N/A
- PLX N/A
- Industry
- SFBC Savings Institutions
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SFBC Finance
- PLX Health Care
- Exchange
- SFBC Nasdaq
- PLX Nasdaq
- Market Cap
- SFBC 112.5M
- PLX 127.4M
- IPO Year
- SFBC N/A
- PLX 1998
- Fundamental
- Price
- SFBC $48.66
- PLX $1.65
- Analyst Decision
- SFBC
- PLX Strong Buy
- Analyst Count
- SFBC 0
- PLX 1
- Target Price
- SFBC N/A
- PLX $15.00
- AVG Volume (30 Days)
- SFBC 5.0K
- PLX 529.0K
- Earning Date
- SFBC 07-29-2025
- PLX 08-14-2025
- Dividend Yield
- SFBC 1.61%
- PLX N/A
- EPS Growth
- SFBC 59.31
- PLX N/A
- EPS
- SFBC 2.43
- PLX 0.08
- Revenue
- SFBC $38,045,000.00
- PLX $61,948,000.00
- Revenue This Year
- SFBC N/A
- PLX $10.00
- Revenue Next Year
- SFBC N/A
- PLX $83.13
- P/E Ratio
- SFBC $20.04
- PLX $21.44
- Revenue Growth
- SFBC 8.26
- PLX 62.79
- 52 Week Low
- SFBC $44.00
- PLX $0.89
- 52 Week High
- SFBC $55.99
- PLX $3.10
- Technical
- Relative Strength Index (RSI)
- SFBC 61.41
- PLX 59.62
- Support Level
- SFBC $46.24
- PLX $1.47
- Resistance Level
- SFBC $48.23
- PLX $1.57
- Average True Range (ATR)
- SFBC 0.67
- PLX 0.08
- MACD
- SFBC 0.23
- PLX 0.01
- Stochastic Oscillator
- SFBC 94.02
- PLX 88.46
About SFBC Sound Financial Bancorp Inc.
Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.